Caffeine, mood and mental performance in everyday life

Nutrition Bulletin

Volumn 32, Issue SUPPL.1, 2007, Pages 84-89

  Rogers, Peter J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Caffeine; Cognitive function; Mood; Performance

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; CAFFEINE; PSYCHOSTIMULANT AGENT;

ALERTNESS; ANXIETY; DAILY LIFE ACTIVITY; DIETARY INTAKE; HUMAN; MENTAL DETERIORATION; MENTAL PERFORMANCE; MOOD; NEUROPROTECTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SENESCENCE;

EID: 33947123709     PISSN: 14719827     EISSN: 14673010     Source Type: Journal    
DOI: 10.1111/j.1467-3010.2007.00607.x     Document Type: Review

References (32)

1. 2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 28: 1694-702.
2. Basheer R, Strecker RE, Thakkar MM et al. (2004) Adenosine and sleep-wake regulation. Progress in Neurobiology 73: 379-96.
3. Childs E & de Wit H (2006) Subjective, behavioral, and physiological effects of acute caffeine in light, nondependent caffeine users. Psychopharmacology 185: 514-23.
4. 2a gene to the development of the disease. Molecular Psychiatry 3: 81-5.
5. Fredholm BB, Bättig K, Holmén J et al. (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacological Reviews 51: 83-133.
6. Fredholm BB, Chen J-F, Cunha RA et al. (2005) Adenosine and brain function. International Review of Neurobiology 63: 191-270.
7. Haskell CF, Kennedy DO, Wesnes KA et al. (2005) Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine. Psychopharmacolgy 179: 813-25.
8. Heatherley SV, Hayward RC, Seers HE et al. (2005) Cognitive and psychomotor performance, mood, and pressor effects of caffeine after 4, 6 and 8 h caffeine abstinence. Psychopharmacology 178: 461-70.
9. Heatherley SV, Mullings EL, Tidbury MA et al. (2006) Caffeine consumption among a sample of UK adults. Appetite 47: 266.
10. Horne JA & Reyner LA (1996) Counteracting driver sleepiness: Effects of napping, caffeine and placebo. Psychophysiology 33: 306-9.
11. Hughes RN (1996) Drugs which induce anxiety: Caffeine. New Zealand Journal of Psychology 25: 36-42.
12. James JE (2004) Critical review of dietary caffeine and blood pressure: a relationship that should be taken more seriously. Psychosomatic Medicine 6: 63-71.
13. James JE & Rogers PJ (2005) Effects of caffeine on performance and mood: Withdrawal reversal is the most plausible explanation. Psychopharmacology 182: 1-8.
14. Jarvis MJ (1993) Does caffeine enhance intake above absolute levels of cognitive performance? Psychopharmacology 110: 45-52.
15. Johnson-Kozlow M, Kritz-Silverstein D, Barrett-Connor E et al. (2002) Coffee consumption and cognitive function among older adults. American Journal of Epidemiology 156: 842-50.
16. Jones HE, Herning RI, Cadet JL et al. (2000) Caffeine withdrawal increases cerebral blood flow velocity and alters quantitative electroencephalography (EEG) activity. Psychopharmacology 147: 371-7.
17. Juliano LM & Griffiths RR (2004) A critical review of caffeine withdrawal: Empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology 176: 1-29.
18. Lieberman HR, Tharion WJ, Shulitt-Hale B et al. (2002) Effects of caffeine, sleep loss, and stress on cognitive performance and mood during U.S. Navy SEAL training. Psychopharmacology 164: 250-61.
19. O'Brien J, Ames D, Gustafson L et al. (2004) Cerebrovascular Disease, Cognitive Impairment and Dementia. Martin Dunitz: London.
20. Richardson NJ, Rogers PJ, Elliman NA et al. (1995) Mood and performance effects of caffeine in relation to acute and chronic caffeine deprivation. Pharmacology Biochemistry and Behavior 52: 313-20.
21. Robelin M & Rogers PJ (1998) Mood and psychomotor performance effects of the first, but not of subsequent, cup-of-coffee equivalent doses of caffeine consumed after overnight caffeine abstinence. Behavioural Pharmacology 9: 611-18.
22. Rogers PJ & Dernoncourt C (1998) Regular caffeine consumption: A balance of adverse and beneficial effects for mood and psychomotor performance. Pharmacology Biochemistry and Behavior 59: 1039-45.
23. Rogers PJ & Richardson NJ (1993) Why do we like drinks that contain caffeine? Trends in Food Science and Technology 4: 108-11.
24. Rogers PJ, Martin J, Smith C et al. (2003) Absence of reinforcing, mood and psychomotor performance effects of caffeine in habitual non-consumers of caffeine. Psychopharmacology 167: 54-62.
25. Rogers PJ, Heatherley SV, Hayward RC et al. (2005) Effects of caffeine and caffeine withdrawal on mood and cognitive performance degraded by sleep restriction. Psychopharmacology 179: 742-52.
26. Rogers PJ, Heatherley SV, Mullings EL et al. (2006) Licit drug use and depression, anxiety and stress. Journal of Psychopharmacology 20 (Suppl.): A27.
27. Ross GW, Abbott RD, Petrovitch H et al. (2000) Association between coffee and caffeine intake with the risk of Parkinson disease. Journal of the American Medical Association 283: 2674-9.
28. Smit HJ & Rogers PJ (2000) Effects of low doses of caffeine on cognitive performance, mood and thirst in low and higher caffeine consumers. Psychopharmacology 152: 167-73.
29. Stewart R (1999) Hypertension and cognitive decline. British Journal of Psychiatry 174: 286-7.
30. Stewart R & Liolitsa D (1999) Type 2 diabetes mellitus, cognitive impairment and dementia. Diabetic Medicine 16: 93-112.
31. Tuomilehto J, Hu G, Bidel S et al. (2004) Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. Journal of the American Medical Association 291: 1213-19.
32. Vautrin S, Pelloux Y & Costentin J (2005) Preference for caffeine appears earlier in non-anxious than in anxious mice. Neuroscience Letters 386: 94-8.